China’s Duality Biologics secures $90m in Series B led by Lilly Asia Ventures

China’s Duality Biologics secures $90m in Series B led by Lilly Asia Ventures

Photo: Pixabay

Liya Su

20 May, 2021

Duality BiologicsLily Asia Ventures

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.